Dockets

Federal rulemakings, soonest-closing first — each gathers its documents and comments.

NonrulemakingFDA

Food and Drug Administration’s Foods Program Guidance Agenda

1
document
9
comments
Last activity Jun 30, 2026View docket →
NonrulemakingFDA

Requests that the FDA Limit the Exposure of Refined Carbohydrates used in Industrial Processing in order to Prevent Obesity, Diabetes, and Cardiovascular Disease in Children and Adults

1
document
496
comments
Last activity Jun 30, 2026View docket →
NonrulemakingFDA

Request that the FDA implement urgent and decisive measures to protect animal and public health in light of mounting evidence regarding the risks associated with Zorbium (buprenorphine, NADA 141547, Schedule III opioid)

1
document
6
comments
Last activity Jun 29, 2026View docket →
NonrulemakingNHTSA

Request for Comments on Barriers and Solutions for Submitting Data to the Fatality Analysis and Reporting System Pursuant to Recommendations for Toxicological Investigation of Drug-Impaired Driving and Motor Vehicle Fatalities

1
document
10
comments
Last activity Jun 29, 2026View docket →
NonrulemakingDOT

Revitalizing Washington Dulles International Airport

1
document
1
comments
Last activity Jun 28, 2026View docket →
NonrulemakingFAA

Tactical Electronics and Military Supply LLC - Exemption/Rulemaking

3
documents
1
comments
Last activity Jun 28, 2026View docket →
NonrulemakingFDA

Requests that the FDA order and/or take an administrative action, as provided in the below proposed order; under the Authority: 5 U.S.C. §551-§558, §701-§706; 15 U.S.C. §1451-§1461; 21 U.S.C. §141-§149, §321-§397, §467f, §679, §821, §1034; 28 U.S.C. §2112; 42 U.S.C. §201, §262, §263b, §264.

30
documents
36
comments
Last activity Jun 28, 2026View docket →
NonrulemakingFDA

Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards

7
documents
9
comments
Last activity Jun 27, 2026View docket →
NonrulemakingFDA

Requests that the FDA require revisions to the labeling for all over-the-counter acetaminophen-containing drug products marketed under the Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use monograph (OTC Monograph M013): (i) a revision to the “Warnings” subsection, currently found at M013.50(c)(1)(iii) in the Labeling section.

1
document
315
comments

1 awaiting analysis

Last activity Jun 27, 2026View docket →
NonrulemakingFDA

Requests that FDA, under FDCA §505G(b) (OTC monograph administrative order process), amend OTC Monograph M013 to update Drug Facts labeling for all over-the-counter acetaminophen-containing products. In the alternative, Petitioner asks FDA to initiate such an order on its own

2
documents
43
comments
Last activity Jun 27, 2026View docket →
NonrulemakingFDA

Requests that the Food and Drug Administration issue a written determination regarding the regulatory status of fluoride compounds distributed for community water fluoridation

9
documents
6
comments
Last activity Jun 25, 2026View docket →
RulemakingNHTSA

Rear Designated Seating Position Alert

1
document
24
comments
Last activity Jun 24, 2026View docket →